Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1987 1
1989 2
1990 1
1994 2
1995 4
1996 3
1997 2
1998 3
1999 11
2000 9
2001 2
2002 9
2003 12
2004 5
2005 10
2006 11
2007 12
2008 23
2009 18
2010 17
2011 10
2012 9
2013 3
2014 2
2015 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

178 results
Results by year
Filters applied: . Clear all
Page 1
Primary biliary cirrhosis.
Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Lindor KD, et al. Among authors: heathcote ej. Hepatology. 2009 Jul;50(1):291-308. doi: 10.1002/hep.22906. Hepatology. 2009. PMID: 19554543 No abstract available.
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.
Sharma SA, Kowgier M, Hansen BE, Brouwer WP, Maan R, Wong D, Shah H, Khalili K, Yim C, Heathcote EJ, Janssen HLA, Sherman M, Hirschfield GM, Feld JJ. Sharma SA, et al. Among authors: heathcote ej. J Hepatol. 2017 Aug 24:S0168-8278(17)32248-1. doi: 10.1016/j.jhep.2017.07.033. Online ahead of print. J Hepatol. 2017. PMID: 28844936
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Marcellin P, et al. Among authors: heathcote ej. Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10. Lancet. 2013. PMID: 23234725 Clinical Trial.
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, Heathcote EJ, Manns MP, Kuske L, Zeuzem S, Hofmann WP, de Knegt RJ, Hansen BE, Janssen HL. van der Meer AJ, et al. Among authors: heathcote ej. JAMA. 2012 Dec 26;308(24):2584-93. doi: 10.1001/jama.2012.144878. JAMA. 2012. PMID: 23268517
Primary biliary cirrhosis.
Kumagi T, Heathcote EJ. Kumagi T, et al. Among authors: heathcote ej. Orphanet J Rare Dis. 2008 Jan 23;3:1. doi: 10.1186/1750-1172-3-1. Orphanet J Rare Dis. 2008. PMID: 18215315 Free PMC article. Review.
Cholestasis and cholestatic syndromes.
Hirschfield GM, Heathcote EJ. Hirschfield GM, et al. Among authors: heathcote ej. Curr Opin Gastroenterol. 2009 May;25(3):175-9. doi: 10.1097/mog.0b013e32832914b4. Curr Opin Gastroenterol. 2009. PMID: 19396955 Review.
Autoimmune cholangitis.
Heathcote EJ. Heathcote EJ. Clin Liver Dis. 1998 May;2(2):303-11, viii-ix. doi: 10.1016/s1089-3261(05)70009-x. Clin Liver Dis. 1998. PMID: 15560034 Review.
Epidemiology of autoimmune liver disease.
Feld JJ, Heathcote EJ. Feld JJ, et al. Among authors: heathcote ej. J Gastroenterol Hepatol. 2003 Oct;18(10):1118-28. doi: 10.1046/j.1440-1746.2003.03165.x. J Gastroenterol Hepatol. 2003. PMID: 12974897 Review.
Primary biliary cirrhosis: the future.
Hirschfield GM, Heathcote EJ. Hirschfield GM, et al. Among authors: heathcote ej. Clin Liver Dis. 2008 May;12(2):473-9; xi. doi: 10.1016/j.cld.2008.02.002. Clin Liver Dis. 2008. PMID: 18456192 Review.
Antimitochondrial antibody-negative primary biliary cirrhosis.
Hirschfield GM, Heathcote EJ. Hirschfield GM, et al. Among authors: heathcote ej. Clin Liver Dis. 2008 May;12(2):323-31; viii-ix. doi: 10.1016/j.cld.2008.02.003. Clin Liver Dis. 2008. PMID: 18456183 Review.
178 results
Jump to page